SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-021447
Filing Date
2020-11-16
Accepted
2020-11-16 08:57:43
Documents
74
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 1479447
2 ex31-1.htm EX-31.1 19948
3 ex31-2.htm EX-31.2 20234
4 ex32-1.htm EX-32.1 8599
  Complete submission text file 0001493152-20-021447.txt   5272761

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE clsn-20200930.xml EX-101.INS 707068
6 XBRL SCHEMA FILE clsn-20200930.xsd EX-101.SCH 71946
7 XBRL CALCULATION FILE clsn-20200930_cal.xml EX-101.CAL 74241
8 XBRL DEFINITION FILE clsn-20200930_def.xml EX-101.DEF 227714
9 XBRL LABEL FILE clsn-20200930_lab.xml EX-101.LAB 465691
10 XBRL PRESENTATION FILE clsn-20200930_pre.xml EX-101.PRE 326310
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Celsion CORP (Filer) CIK: 0000749647 (see all company filings)

IRS No.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15911 | Film No.: 201313947
SIC: 2834 Pharmaceutical Preparations